141 related articles for article (PubMed ID: 20230917)
1. Oral adjuvant activity for nasal influenza vaccines caused by combination of two trihydroxy fatty acid stereoisomers from the tuber of Pinellia ternata.
Nagai T; Shimizu Y; Shirahata T; Sunazuka T; Kiyohara H; Omura S; Yamada H
Int Immunopharmacol; 2010 Jun; 10(6):655-61. PubMed ID: 20230917
[TBL] [Abstract][Full Text] [Related]
2. Pinellic acid from the tuber of Pinellia ternata Breitenbach as an effective oral adjuvant for nasal influenza vaccine.
Nagai T; Kiyohara H; Munakata K; Shirahata T; Sunazuka T; Harigaya Y; Yamada H
Int Immunopharmacol; 2002 Jul; 2(8):1183-93. PubMed ID: 12349955
[TBL] [Abstract][Full Text] [Related]
3. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model.
Nagai T; Arai Y; Emori M; Nunome SY; Yabe T; Takeda T; Yamada H
Int Immunopharmacol; 2004 Oct; 4(10-11):1353-65. PubMed ID: 15313433
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis and adjuvant activity of all stereoisomers of pinellic acid.
Shirahata T; Sunazuka T; Yoshida K; Yamamoto D; Harigaya Y; Nagai T; Kiyohara H; Yamada H; Kuwajima I; Omura S
Bioorg Med Chem Lett; 2003 Mar; 13(5):937-41. PubMed ID: 12617925
[TBL] [Abstract][Full Text] [Related]
5. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
[TBL] [Abstract][Full Text] [Related]
6. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
[TBL] [Abstract][Full Text] [Related]
7. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
[TBL] [Abstract][Full Text] [Related]
8. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
[TBL] [Abstract][Full Text] [Related]
12. Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine.
Ainai A; Ichinohe T; Tamura S; Kurata T; Sata T; Tashiro M; Hasegawa H
J Med Virol; 2010 Mar; 82(3):476-84. PubMed ID: 20087927
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
Shim DH; Ko HJ; Volker G; Potter AA; Mutwiri G; Babiuk LA; Kweon MN
Vaccine; 2010 Mar; 28(11):2311-7. PubMed ID: 20060944
[TBL] [Abstract][Full Text] [Related]
15. Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.
Asanuma H; Fujihashi K; Miyakoshi T; Yoshikawa T; Fujita-Yamaguchi Y; Kojima N; Nakata M; Suzuki Y; Tamura S; Kurata T; Sata T
Vaccine; 2007 Sep; 25(39-40):6975-80. PubMed ID: 17716790
[TBL] [Abstract][Full Text] [Related]
16. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system.
Yamada H; Nagai T
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):185-92. PubMed ID: 9646280
[TBL] [Abstract][Full Text] [Related]
17. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
18. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity.
Arulanandam BP; O'Toole M; Metzger DW
J Infect Dis; 1999 Oct; 180(4):940-9. PubMed ID: 10479116
[TBL] [Abstract][Full Text] [Related]
19. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice.
Nagai T; Yamada H
Immunopharmacol Immunotoxicol; 1998 May; 20(2):267-81. PubMed ID: 9653672
[TBL] [Abstract][Full Text] [Related]
20. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect.
Nagai T; Urata M; Yamada H
Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
